Asia-Pacific Markets for Spinal Implants, VCF, & Biomaterials 2008 (5 countries)

iData Research, Inc.
October 1, 2007
215 Pages - SKU: IDR2156909
License type:
Countries covered: Asia

The Asia-Pacific market for spinal implants and biomaterials represents a significant portion of the world wide orthopedic market. The market is comprised of four main segments: Spinal fusion implants, non-fusion implants, spinal biomaterials, and vertebral compression fracture (VCF) treatment. This report analyses these segments in Australia, China, Japan, South Korea and Taiwan. In 2006, the Asia-Pacific market for spinal implants and biomaterials was valued at over $500 million. The majority of this market value was attributed to spinal fusion implants as depicted in Chart 1-1. Each market segment will experience strong growth in the near future but growth of the non-fusion and VCF markets will help drive double digit growth rates of the total market. By 2013, the market value will reach over $1 billion.


More Asia Drug Discovery Reports

Clinical Trials Market in India 2012 by Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract ...

Chinese Markets for Hepatitis Drugs by Asia Market Information & Development Company
China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ...

Orphan Drugs in Asia 2012 by Pacific Bridge Medical
Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan ...

Cardiovascular and Metabolic Diseases Market Access in China by Datamonitor
The large and growing number of cardiovascular and metabolic diseases (CVMDs) patients in China translates into significant ...

China Benign Prostate Hyperplasia Prescription Drug Sales Data 2006-2010 by Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...

See all reports like this >>

More Asia Reports

D&B Country RiskLine Report: Vietnam by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Uzbekistan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Turkmenistan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Turkey by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Thailand by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

See all reports like this >>